R-Pharm
| Use attributes for filter ! | |
| Founders | Aleksey Repik |
|---|---|
| Founded | 2001 |
| Ceo | Vasily Ignatiev |
| Subsidiaries | R-Pharm Germany Gmbh |
| R-Pharm-US LLC | |
| ZAO Ortat | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 4083053 |
About R-Pharm
R-Pharm is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection.